We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Participation to Colorectal Cancer Screening With Fecal Occult Blood Test and Colonoscopy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00812942
First Posted: December 22, 2008
Last Update Posted: December 22, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Istituto Superiore di Sanità
  Purpose
Adherence rate to screening colonoscopy (TC) in the average-risk general population is still unclear. Aim of this study was to compare the uptake of TC screening with that of fecal occult blood (FOBT) in the general population of different Italian areas.

Condition Intervention
Colorectal Cancer Procedure: colonoscopy Procedure: faecal test

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Participation to Colorectal Cancer Screening With Faecal Occult Blood Test and Colonoscopy: an Italian, Multicenter, Randomized Population Study

Resource links provided by NLM:


Further study details as provided by Istituto Superiore di Sanità:

Primary Outcome Measures:
  • Participation to colorectal cancer screening

Enrollment: 9889
Study Start Date: November 2003
Study Completion Date: November 2008
Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: fobt
faecal occult blood test
Procedure: faecal test
faecal occult blood test for screening
Active Comparator: colonoscopy
colonoscopy screening
Procedure: colonoscopy
colonoscopy screening

Detailed Description:
A nationwide, population-based, multicenter, randomized trial comparing attendance to TC with that to FOBT was performed. Sixty-four general practitioners (GPs), overall including in their lists 9,889 average-risk subjects aged 55-64 years, were randomized between TC and FOBT screening programs. Eligible subjects were mailed a personal invitation letter co-signed by their GP and the coordinator of the area-reference GI centre. Attendance rate and detection rate for advanced neoplasia (colorectal cancer, adenoma >10 mm or with villous histology or high-grade dysplasia) for each arm of the study were assessed.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   55 Years to 64 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • asymptomatic 55-64 years subjects

Exclusion Criteria:

  • already studied for colorectal cancer, severe comorbidities
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00812942


Locations
Italy
IIstituto Nazionale Tumori Regina Elena
Rome, Italy, 00100
Sponsors and Collaborators
Istituto Superiore di Sanità
  More Information

ClinicalTrials.gov Identifier: NCT00812942     History of Changes
Other Study ID Numbers: 1
First Submitted: December 18, 2008
First Posted: December 22, 2008
Last Update Posted: December 22, 2008
Last Verified: December 2008

Keywords provided by Istituto Superiore di Sanità:
average-risk subjects for

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases